Given Zydus Lifesciences and Dr Reddy’s Laboratories have high US sales exposure with ~45% and 43% sales contribution, ...

Zydus Lifesciences is a standout in terms of HR practices. From revision in pay to performance parameters, everything is ...

Pharmaceutical company shares faced significant selling pressure, causing the Nifty Pharma index to decline by more than 2 ...

The rise in the Zydus Lifesciences shares came after the company received final approval from the United States Food and Drug ...

Zydus Lifesciences shares will be in focus on Wednesday after the company secured final approval from the US Food and Drug ...

Apalutamide is an androgen receptor inhibitor indicated for the treatment of patients with metastatic castration-sensitive ...

Zydus Lifesciences shares rose 8.34 per cent on March 19, touching an intraday high of Rs 910.30  at 1:00 PM when the company ...

Despite the recent correction, the number of Rs1 lakh crore-plus market cap firms has slightly increased between the end of FY24 and early FY25. For perspective, FY23 and FY22 each recorded 48 ...

Mumbai's real estate sector continues to grow with a record number of high-value sales as billionaires, Bollywood celebrities ...

Zydus Lifesciences rose 3% to an intra-day high of Rs 930 after the company received approval from the US FDA to manufacture ...

Zydus Family Trust purchased a luxury apartment in Mumbai's Oberoi Realty project for ₹200 crore. Covering 17,384 sq ft, the ...

Zydus Lifesciences received final USFDA approval to manufacture Apalutamide tablets for prostate cancer, following last ...